Please assess the completion status of the following clinical trial:

Trial Title: Study Evaluating 13-valent Pneumococcal Conjugate Vaccine In Healthy Infants

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion criteria:~* Healthy 2 month old infants~* Available for the duration of the study and reachable by telephone~* Able to complete two blood drawing procedures during the study~Exclusion criteria:~* Previous vaccination, contraindication or history of allergic reaction to vaccines or vaccine components~* Bleeding disorder, immune deficiency or significant chronic or congenital disease~* Previous receipt of blood products or immune globulin

- Gender: ALL
- Minimum Age: 42 Days
- Maximum Age: 98 Days
- Healthy Volunteers: t

Study Arms:
- 1 (Type: EXPERIMENTAL): None
- 2 (Type: EXPERIMENTAL): None
- 3 (Type: EXPERIMENTAL): None
- 4 (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).